LT-3122

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLT-3122
Drug Alias NameLT-3122
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLipicard Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipicard Technologies
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A